Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sanjay Mendiratta

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Virusdisease|July 14, 2020
COVID-19 diagnostic approaches: different roads to the same destinationRamesh Kumar, Suman Nagpal, Samander Kaushik, et al.
BMC Public Health|July 15, 2010
Late presenters to HIV care and treatment, identification of associated risk factors in HIV-1 infected Indian populationKamalika Mojumdar, Madhu Vajpayee, Neeraj K Chauhan, et al.
The Indian Journal of Medical Research|September 18, 2010
Defects in blood dendritic cell subsets in HIV-1 subtype c infected IndiansKamalika Mojumdar, Madhu Vajpayee, Neeraj Kumar Chauhan, et al.
Vaccine|December 22, 2010
Polyfunctional analysis of Gag and Nef specific CD8+ T-cell responses in HIV-1 infected Indian individualsSanjay Mendiratta, Madhu Vajpayee, Kamalika Mojumdar, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|February 14, 2025
Estimation of protein aggregates in Darbepoetin alfa formulations by developing a single validated analytical methodNupur Garg, Sanjay Mendiratta, Gurminder Bindra, et al.
Medical Microbiology and Immunology|November 6, 2008
Characterization of Gag and Nef-specific ELISpot-based CTL responses in HIV-1 infected Indian individualsSanjay Mendiratta, Madhu Vajpayee, Uma Malhotra, et al.
Journal of Pharmaceutical and Biomedical Analysis|March 28, 2024
Less is more: Validating a single method for comprehensive rh-insulin analysisSanjay Mendiratta, Gurminder Bindra, Sukhwinder Singh, et al.
3 Biotech|August 11, 2025
Analytical assessment of safety and efficacy of filgrastim and pegfilgrastim formulations for treatment of chemotherapy-induced neutropeniaNupur Garg, Birendra Kumar, Sanjay Mendiratta, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Virusdisease|July 14, 2020
COVID-19 diagnostic approaches: different roads to the same destinationRamesh Kumar, Suman Nagpal, Samander Kaushik, et al.
BMC Public Health|July 15, 2010
Late presenters to HIV care and treatment, identification of associated risk factors in HIV-1 infected Indian populationKamalika Mojumdar, Madhu Vajpayee, Neeraj K Chauhan, et al.
The Indian Journal of Medical Research|September 18, 2010
Defects in blood dendritic cell subsets in HIV-1 subtype c infected IndiansKamalika Mojumdar, Madhu Vajpayee, Neeraj Kumar Chauhan, et al.
Vaccine|December 22, 2010
Polyfunctional analysis of Gag and Nef specific CD8+ T-cell responses in HIV-1 infected Indian individualsSanjay Mendiratta, Madhu Vajpayee, Kamalika Mojumdar, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|February 14, 2025
Estimation of protein aggregates in Darbepoetin alfa formulations by developing a single validated analytical methodNupur Garg, Sanjay Mendiratta, Gurminder Bindra, et al.
Medical Microbiology and Immunology|November 6, 2008
Characterization of Gag and Nef-specific ELISpot-based CTL responses in HIV-1 infected Indian individualsSanjay Mendiratta, Madhu Vajpayee, Uma Malhotra, et al.
Journal of Pharmaceutical and Biomedical Analysis|March 28, 2024
Less is more: Validating a single method for comprehensive rh-insulin analysisSanjay Mendiratta, Gurminder Bindra, Sukhwinder Singh, et al.
3 Biotech|August 11, 2025
Analytical assessment of safety and efficacy of filgrastim and pegfilgrastim formulations for treatment of chemotherapy-induced neutropeniaNupur Garg, Birendra Kumar, Sanjay Mendiratta, et al.
Pageof 1